Evaluation of the Etest and disk diffusion method for detection of the activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa in China

BACKGROUND: Ceftazidime-avibactam was approved in China in 2019 for treating complicated intra-abdominal infections, hospital-acquired pneumonia, ventilator-associated pneumonia, and infections caused by Enterobacterales and Pseudomonas aeruginosa for which treatment options are limited. However, no...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qi, Zhang, Feifei, Wang, Zhanwei, Chen, Hongbin, Wang, Xiaojuan, Zhang, Yawei, Li, Shuguang, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325266/
https://www.ncbi.nlm.nih.gov/pubmed/32600252
http://dx.doi.org/10.1186/s12866-020-01870-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325266/
https://www.ncbi.nlm.nih.gov/pubmed/32600252
http://dx.doi.org/10.1186/s12866-020-01870-z

Ejemplares similares